Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.2.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.3.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.3.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LU.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LU.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LU.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LU.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LU.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LU.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LU.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LU.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LF.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LF.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LF.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LF.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LF.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
LB.1.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
LB.1.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
LB.1.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
LB.1.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
LB.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LB.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.43.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.43.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.43.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.43.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.43.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.43.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.43.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.28EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.28ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.28ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.28EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.28EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.1.28ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
JN.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
JN.1.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JN.1.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.1.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used